Jim Cramer Says He Cannot Recommend UiPath
UiPath Inc. (NYSE:PATH) is one of the stocks Jim Cramer commented on. During the lightning round, when a caller inquired about the stock, Cramer remarked:
“I’ll tell you the truth… It just had such a big move. I can’t recommend it. It just, just soared. It’s not for me.”
A stock market data. Photo by Alesia Kozik on Pexels
UiPath Inc. (NYSE:PATH) provides an automation platform that uses robotic process automation and AI to help organizations automate repetitive tasks. On October 2, BMO Capital analyst Keith Bachman raised UiPath’s stock price target from $12.50 to $13 while maintaining a Market Perform rating. The analyst noted the company’s announcement of new products and partnerships but warned that the competitive market may delay the impact of these investments on revenue growth. Additionally, on October 8, Barclays reiterated a Hold rating on the company’s stock with a price target of $14.
While we acknowledge the potential of PATH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
Content Original Link:
" target="_blank">
